RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. It has been highlighted that there is image manipulation. Fig. 6 b), e) ad f) are the same images from Fig 5 a), b), c) from Patil, S.P., Jain, P.D., Ghumatkar, P.J., Tambe, R., Sathaye, S., 2014. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience 277, 747–754 and used to describe different drug doses and treatments in the paper. Fig. 8 d), e) and f) are the same image manipulated to be results for different drug treatments. Fig. 10a), b) and h) are the same images as Fig. 7 B) in the paper Patil, S.P., Jain, P.D., Ghumatkar, P.J., Tambe, R., Sathaye, S., 2014. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience 277, 747–754 and used to describe different drug treatments. The authors acknowledge there are serious errors and agree with the retraction of this paper.

Keywords: Apigenin; Luteolin; Neuroprotective; Neurotrophic; Parkinson's disease.